Zomedica Pharmaceuticals Corp. | Business Contracts

Offer Letter, dated March 15, 2023, between Zomedica Inc. and Peter Donato (Filed With SEC on March 17, 2023)

Separation Agreement, dated March 16, 2023, between Zomedica Inc. and Ann Marie Cotter (Filed With SEC on March 17, 2023)

License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022 (Filed With SEC on March 15, 2023)

BAW Sensor Supply Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp (Filed With SEC on January 24, 2023)

Lease Agreement, effective July 1, 2022 by and between Zomedica Inc. and Lebow 1031 Legacy, LLC (Filed With SEC on November 14, 2022)

Note receivable agreement, effective May 16, 2022, by and between Zomedica, Inc. and Structured Monitoring Products, Inc (Filed With SEC on August 15, 2022)

Form of Indemnity (Filed With SEC on March 15, 2023)

Development and Manufacturing License Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp (Filed With SEC on January 24, 2023)

Transition and Support Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp (Filed With SEC on January 24, 2023)

Structured Monitoring Products, Inc. Distribution Agreement dated January 13, 2023 by and between Zomedica Inc. and Structured Monitoring Products, Inc (Filed With SEC on January 20, 2023)

Lease Agreement, effective April 1, 2022, by and between Zomedica Inc. and ULF Northfield Business Center (Filed With SEC on August 15, 2022)

Consulting Agreement, effective June 17, 2022, by and between Zomedica Corp. and Dr. Stephanie Morley (Filed With SEC on August 15, 2022)

Asset Purchase Agreement dated July 15, 2022 by and among Assisi Animal Health LLC, AAH Holdings LLC, the Principal Members (as defined therein), Zomedica Inc. and Zomedica Corp (Filed With SEC on July 20, 2022)

Warrant to Purchase Common Shares dated July 15, 2022 issued to Assisi Animal Health LLC (Filed With SEC on July 20, 2022)

Warrant to Purchase Common Shares dated July 1, 2022 issued to Revo Squared LLC (Filed With SEC on July 11, 2022)

Asset Purchase Agreement dated June 14, 2022 by and among Revo Squared LLC, the Principal Member (as defined therein), Zomedica Inc. and Zomedica Corp (Filed With SEC on June 21, 2022)

Consulting Agreement, effective March 1, 2022, by and between Zomedica Inc. and Johnny D. Powers (Filed With SEC on May 10, 2022)

Summary of Compensation Arrangements with Ann Marie Cotter (Filed With SEC on March 1, 2022)

Confidential Separation Agreement and Release Agreement, dated November 19, 2021, between Zomedica Inc. and Bruk Herbst (Filed With SEC on November 26, 2021)

Executive Employment Agreement, dated September 6, 2019, by and between Pulse Veterinary Technologies, LLC and Adrian Lock (Filed With SEC on November 12, 2021)

Second Lease Agreement, effective September 15, 2021, by and between Zomedica Inc. and Wickfield Phoenix LLC (Filed With SEC on November 12, 2021)

Executive Employment Agreement, dated October 1, 2021, among Zomedica Inc., Zomedica Corp. and Larry Heaton (Filed With SEC on October 4, 2021)

Stock Purchase Agreement dated October 1, 2021 by and between Zomedica Inc. and Branford PVT Mid-Hold, LLC (Filed With SEC on October 1, 2021)

Consulting Agreement between the Company and Stephanie Morley, dated May 14, 2021 (Filed With SEC on May 17, 2021)

Separation Agreement between the Company and Stephanie Morley, dated May 14, 2021 (Filed With SEC on May 17, 2021)

Form of Indemnity (Filed With SEC on February 26, 2021)

Amended and Restated Underwriting Agreement, dated February 8, 2021, between Zomedica Corp. and H.C. Wainwright & Co., LLC (Filed With SEC on February 9, 2021)

Executive Employment Agreement, dated January 1, 2021 among Zomedica Pharmaceuticals, Inc., Zomedica Corp. and Robert Cohen (Filed With SEC on January 5, 2021)

Executive Employment Agreement, dated July 1, 2017, by and between Zomedica Pharmaceuticals Inc. and Bruk Herbst, and the amendments thereto dated November 19, 2020 and December... (Filed With SEC on December 23, 2020)

Executive Employment Agreement, dated September 19, 2019, by and between Zomedica Pharmaceuticals Inc. and Stephanie Morley, and the amendment thereto dated December 23, 2020 (Filed With SEC on December 23, 2020)

Letter Agreement, dated September 3, 2020, with Qorvo Biotechnologies, LLC (Filed With SEC on October 9, 2020)

Amendment, dated August 14, 2020, to Development and Supply Agreement with Qorvo Biotechnologies, LLC (Filed With SEC on October 9, 2020)

Form of Series D Warrant (Filed With SEC on July 6, 2020)

Form of Securities Purchase Agreement, dated July 1, 2020, by and among the Company and the purchasers party thereto (Filed With SEC on July 6, 2020)

Placement Agency Agreement, dated July 1, 2020, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on July 6, 2020)

Form of Pre-Funded Warrant (Filed With SEC on July 6, 2020)

Amended and Restated Executive Employment Agreement, dated June 16, 2020, among Zomedica Pharmaceuticals, Inc., Zomedica Pharmaceuticals Corp. and Robert Cohen (Filed With SEC on July 1, 2020)

Executive Employment Agreement, dated June 16, 2020, among Zomedica Pharmaceuticals, Inc., Zomedica Pharmaceuticals Corp. and Robert Cohen (Filed With SEC on June 17, 2020)

Form of Placement Agency Agreement to be entered into by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 22, 2020)

Form of Securities Purchase Agreement to be entered into among the Company and certain investors (Filed With SEC on May 15, 2020)

Form of Pre-Funded Warrant (Filed With SEC on May 15, 2020)

Form of Placement Agent Warrant (Filed With SEC on May 15, 2020)

Form of Placement Agency Agreement to be entered into by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 15, 2020)

Form of Series C Warrant (Filed With SEC on May 15, 2020)

Promissory Note, between Bank of America, NA and Zomedica Pharmaceuticals Corp., dated April 15, 2020 (Filed With SEC on April 24, 2020)

Placement Agency Agreement, dated April 7, 2020, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on April 8, 2020)

Form of Warrant (Filed With SEC on April 8, 2020)

Form of Securities Purchase Agreement, dated April 7, 2020, by and between the Company and the purchasers party thereto (Filed With SEC on April 8, 2020)

Form of Placement Agent Warrant (Filed With SEC on April 8, 2020)

Consulting Agreement between Zomedica Pharmaceuticals Corp. and Johnny D. Powers (Filed With SEC on February 26, 2020)

Description of Securities (Filed With SEC on February 26, 2020)

Amended and Restated Exclusive License and Supply Agreement, dated January 17, 2020, by and between Celsee, Inc. and Zomedica Pharmaceuticals Corp (Filed With SEC on February 26, 2020)

Lease Agreement for 100 Phoenix Drive, Ann Arbor, 48108 (Filed With SEC on February 26, 2020)

Form of Warrant (Filed With SEC on February 13, 2020)

Form of Placement Agent Warrant (Filed With SEC on February 13, 2020)

Form of Securities Purchase Agreement, dated February 12, 2020, by and between the Company and the Purchasers (Filed With SEC on February 13, 2020)

Consulting Agreement among the Company, Zomedica Pharmaceuticals, Inc. and Gerald Solensky, Jr. dated December 2, 2019 (Filed With SEC on December 3, 2019)

Cooperation Agreement between the Company and Gerald Solensky, Jr. dated December 2, 2019 (Filed With SEC on December 3, 2019)

Separation Agreement between the Company and Gerald Solensky, Jr. dated December 2, 2019 (Filed With SEC on December 3, 2019)

Executive Employment Agreement, dated September 16, 2019, by and between Zomedica Pharmaceuticals Inc. and Stephanie Morley (Filed With SEC on September 17, 2019)

Form of Preferred Share Subscription Agreement for May 2019 Offering (Filed With SEC on May 10, 2019)

Underwriting Agreement, dated March 26, 2019, by an among the Company and the Representative on behalf of the several Underwriters (Filed With SEC on March 27, 2019)

Amendment No. 2 to Executive Employment Agreement between Zomedica Pharmaceuticals Corp. and Gerald Solensky, Jr (Filed With SEC on February 26, 2019)

Development and supply agreement with Qorvo Biotechnologies, LLC (Filed With SEC on February 26, 2019)

Zomedica Pharmaceuticals Corp. (64)